Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.
about
Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous SystemsAntifibrotic therapies to control cardiac fibrosisPathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New PerspectivesUsing extracellular matrix proteomics to understand left ventricular remodelingOrigin of developmental precursors dictates the pathophysiologic role of cardiac fibroblastsMyofibroblasts: trust your heart and let fate decide.Elevated circulating fibrocyte levels in patients with hypertensive heart disease.Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heartAntibody therapy can enhance AngiotensinII-induced myocardial fibrosis.CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis.The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis.Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.Ischemia-reperfusion injury leads to distinct temporal cardiac remodeling in normal versus diabetic miceReciprocal interaction between macrophages and T cells stimulates IFN-γ and MCP-1 production in Ang II-induced cardiac inflammation and fibrosisMacrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin IIBcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in miceCCR2 regulates the uptake of bone marrow-derived fibroblasts in renal fibrosisProinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin II infusion.Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrixCCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.Tumor necrosis factor: a mechanistic link between angiotensin-II-induced cardiac inflammation and fibrosis.Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in MiceMesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart.Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β SignalingFcγRI mediates serum amyloid P inhibition of fibrocyte differentiationCIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.The Living Scar--Cardiac Fibroblasts and the Injured Heart.Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarctionFibrocytes: emerging effector cells in chronic inflammationRole of Circulating Fibrocytes in Cardiac FibrosisUnique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis.Monocyte and macrophage contributions to cardiac remodeling.Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula.The pathogenesis of cardiac fibrosis.Th1/M1 conversion to th2/m2 responses in models of inflammation lacking cell death stimulates maturation of monocyte precursors to fibroblastsAdiponectin promotes monocyte-to-fibroblast transition in renal fibrosis.Valvular heart diseases in the developing world: developmental biology takes center stage.Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?Function and fate of myofibroblasts after myocardial infarction
P2860
Q26744762-E6CDD721-C41D-42BB-BC3B-817FAC92AE24Q26745841-2F7957AB-9915-4623-B6F9-89A342F96258Q26769997-648E1CE7-5E74-4A1A-AC9B-B497FB0E83F7Q26863127-EF717687-E01C-4515-BA41-8A7FC943A4D6Q26863633-7F8BB766-E97B-41DE-ABA8-265B4F0DC629Q27692541-CBBE2616-6EDD-4C6A-85B1-3D00F9FB0EADQ30419423-FA8E0C56-F363-40BD-85FF-4E8C6F3E41E5Q30471805-1EAC59B8-A326-4DE7-A516-8A5930711C7FQ33614147-AE270268-C874-4F4E-AEEB-67C8827ABBC8Q33874406-CFE10910-F49B-43DC-BDCE-4F0D9BFC8161Q33983785-5EF86BA6-C96C-48C1-B575-1D4871B4505DQ33998649-77331840-E032-4A55-899D-9DDB27FBDBE0Q34162518-496445AE-9CCA-44B7-A375-5A2A9EB4BA55Q34261562-B3C36C36-F9CA-437E-8A2F-1C90EEF70D00Q34264496-6209D20D-27B0-43A0-B53A-48346D756ED4Q34315544-6A08BB89-AA32-4DA6-BE3F-A05182340F27Q34429743-F55869F9-347B-40DC-AD33-AB679E14D448Q35018898-A5E21C5C-25CF-407C-992C-D11534D242FDQ35114753-A06F39F5-60B7-4704-822A-BF0E5D5683EBQ35132702-BA48BBFA-83C9-48EA-9F72-4AB49FCFA66EQ35159918-2F6BF35F-F98E-4F54-845F-70D2D024FEB1Q35196311-50D63863-72C4-42D8-B40A-17338769DF91Q35677290-A52E7CC8-525E-4592-A3EA-92747F61D75AQ35878968-D77CF77D-F08F-4E85-9F35-E1BB29701A2DQ36189856-8C510D26-D2E9-4126-8CB5-CCD93C21237FQ36232242-380B98A5-4AC5-4FF2-855F-01987A1A617EQ36337179-2F3093A9-4A74-47BC-A0AF-637B2866FA49Q36535178-1A57DFFB-A66D-4F7D-A6F7-191377ADB7E8Q36581739-F1CA3DD2-C5FF-45EC-B301-D75273EA02ADQ36690680-2ABCFB2C-CB4A-4B99-93C4-982A6EC8B77BQ36705598-F3258924-0951-48E9-8EE5-42CB202B55B3Q36747783-DB8AE115-05E5-4A38-A7CA-DC18309A5059Q36840151-60118136-5942-4899-A285-EA939EDD01BCQ36923608-240D7936-85C6-47CE-8031-498E0ADA12F3Q37161329-BFB78C27-7707-4587-867B-EB7E77EEE3B3Q37180280-CD9880B2-10FE-404A-A85D-81E68008D2A3Q37202779-274D37A3-0C14-4517-B860-79223A482549Q38014461-69D0CD9C-DADD-4B6A-87D7-415DE9FDD8CCQ38046798-313B7BF1-9E2A-40E7-9324-406EE160B868Q38085345-036EBD53-BFED-4E1E-B1CB-7AFF9F6BD005
P2860
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@en
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@nl
type
label
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@en
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@nl
prefLabel
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@en
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@nl
P2093
P2860
P1476
Monocytic fibroblast precursor ...... I-induced cardiac hypertrophy.
@en
P2093
George E Taffet
Jesus Hermosillo-Rodriguez
Jizhong Cheng
JoAnn Trial
Mark L Entman
Sandra B Haudek
Yanlin Wang
P2860
P304
P356
10.1016/J.YJMCC.2010.05.005
P577
2010-05-19T00:00:00Z